ArticleBioengineering (Basel, Switzerland)2024
Synthesis and Characterization of Iron Nanoparticles from a Bioflocculant Produced by
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Kombucha-Mediated Silver Nanoparticles with Fungicidal Activity Against WHO-PriorityCurrent issues in molecular biology · 2026Article
- Green synthesis and characterization of iron nanoparticles synthesized from bioflocculant for wastewater treatment: A review.Biotechnology notes (Amsterdam, Netherlands) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The intriguing characteristics of nanoparticles have fueled recent advancement in the field of nanotechnology. In the current study, a microbial-based bioflocculant made from the SCOBY of Kombucha tea broth was purified, profiled, and utilized to biosynthesize iron nanoparticles as a capping and reducing agent. UV-visible absorption spectroscopy, transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), transmission electron microscopy (TEM), scanning electron microscopy (SEM), energy-dispersive X-ray analysis (EDX), and TGA were used to characterize the Fe nanoparticles. The FT-IR spectra showed functional groups such as hydroxyl, a halogen (C-Br), and carbonyl, and the alkane (C-H) functional groups were present in both samples (bioflocculant and FeNPs) with the exception of the Fe-O bond, which represented the successful biosynthesis of FeNPs. The TEM investigation revealed that the sizes of the produced iron nanoparticles were between 2.6 and 6.2 nm. The UV-vis spectra revealed peaks at 230 nm for the bioflocculant and for the as-fabricated FeNPs, peaks were around 210, 265, and 330 nm, which confirms the formation of FeNPs. X-ray diffraction presented planes (012), (104), (110), (113), (024), (116), and (533) and these planes correspond to 17.17, 32.58, 33.75, 38.18, 45.31, 57.40, and 72.4° at 2Ө. The presence of Fe nanoparticles presented with 0.82 wt% from the EDX spectrum of the biosynthesized FeNPs. However, Fe content was not present from the bioflocculant. SEM images reported cumulus-like particles of the bioflocculant, while that of FeNPs were agglomerated and hexagonal with sizes between 18 and 50 nm. The TGA of FeNPs showed thermal stability by retaining above 60% of its weight at high temperatures. It can therefore be deduced that the purified bioflocculant produced by a yeast
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.